[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

MRI Contrast Agents Industry Research Report 2023

August 2023 | 85 pages | ID: MD572F3F071BEN
APO Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Highlights

The global MRI Contrast Agents market is projected to reach US$ million by 2029 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2029.

North American market for MRI Contrast Agents is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for MRI Contrast Agents is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The major global companies of MRI Contrast Agents include Bayer, Guerbet Group, Bracco Imaging, GE Healthcare, BeiLu Pharma and Hengrui Medicine, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

The global market for MRI Contrast Agents in Hospitals is estimated to increase from $ million in 2022 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Gadobutrol, which accounted for % of the global market of MRI Contrast Agents in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2023 to 2029.

Report Scope

This report aims to provide a comprehensive presentation of the global market for MRI Contrast Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MRI Contrast Agents.

The MRI Contrast Agents market size, estimations, and forecasts are provided in terms of output/shipments (Liter) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global MRI Contrast Agents market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the MRI Contrast Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Bayer
  • Guerbet Group
  • Bracco Imaging
  • GE Healthcare
  • BeiLu Pharma
  • Hengrui Medicine
Product Type Insights

Global markets are presented by MRI Contrast Agents type, along with growth forecasts through 2029. Estimates on production and value are based on the price in the supply chain at which the MRI Contrast Agents are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows production and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).

MRI Contrast Agents segment by Type
  • Gadobutrol
  • Gadoterate Meglumine
  • Gadobenate Dimeglumine
  • Gadopentetate Dimeglumine
  • Gadoteridol
  • Gadodiamine
  • Others
Application Insights

This report has provided the market size (production and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).

This report also outlines the market trends of each segment and consumer behaviors impacting the MRI Contrast Agents market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the MRI Contrast Agents market.

MRI Contrast Agents segment by Application
  • Hospitals
  • Clinics
Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast value for 2029.
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • China Taiwan
    • Indonesia
    • Thailand
    • Malaysia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the MRI Contrast Agents market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global MRI Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of MRI Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the MRI Contrast Agents industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of MRI Contrast Agents.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of MRI Contrast Agents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of MRI Contrast Agents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of MRI Contrast Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.
1 PREFACE

1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
  1.5.1 Secondary Sources
  1.5.2 Primary Sources

2 MARKET OVERVIEW

2.1 Product Definition
2.2 MRI Contrast Agents by Type
  2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
  1.2.2 Gadobutrol
  1.2.3 Gadoterate Meglumine
  1.2.4 Gadobenate Dimeglumine
  1.2.5 Gadopentetate Dimeglumine
  1.2.6 Gadoteridol
  1.2.7 Gadodiamine
  1.2.8 Others
2.3 MRI Contrast Agents by Application
  2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
  2.3.2 Hospitals
  2.3.3 Clinics
2.4 Global Market Growth Prospects
  2.4.1 Global MRI Contrast Agents Production Value Estimates and Forecasts (2018-2029)
  2.4.2 Global MRI Contrast Agents Production Capacity Estimates and Forecasts (2018-2029)
  2.4.3 Global MRI Contrast Agents Production Estimates and Forecasts (2018-2029)
  2.4.4 Global MRI Contrast Agents Market Average Price (2018-2029)

3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS

3.1 Global MRI Contrast Agents Production by Manufacturers (2018-2023)
3.2 Global MRI Contrast Agents Production Value by Manufacturers (2018-2023)
3.3 Global MRI Contrast Agents Average Price by Manufacturers (2018-2023)
3.4 Global MRI Contrast Agents Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
3.5 Global MRI Contrast Agents Key Manufacturers, Manufacturing Sites & Headquarters
3.6 Global MRI Contrast Agents Manufacturers, Product Type & Application
3.7 Global MRI Contrast Agents Manufacturers, Date of Enter into This Industry
3.8 Global MRI Contrast Agents Market CR5 and HHI
3.9 Global Manufacturers Mergers & Acquisition

4 MANUFACTURERS PROFILED

4.1 Bayer
  4.1.1 Bayer MRI Contrast Agents Company Information
  4.1.2 Bayer MRI Contrast Agents Business Overview
  4.1.3 Bayer MRI Contrast Agents Production Capacity, Value and Gross Margin (2018-2023)
  4.1.4 Bayer Product Portfolio
  4.1.5 Bayer Recent Developments
4.2 Guerbet Group
  4.2.1 Guerbet Group MRI Contrast Agents Company Information
  4.2.2 Guerbet Group MRI Contrast Agents Business Overview
  4.2.3 Guerbet Group MRI Contrast Agents Production Capacity, Value and Gross Margin (2018-2023)
  4.2.4 Guerbet Group Product Portfolio
  4.2.5 Guerbet Group Recent Developments
4.3 Bracco Imaging
  4.3.1 Bracco Imaging MRI Contrast Agents Company Information
  4.3.2 Bracco Imaging MRI Contrast Agents Business Overview
  4.3.3 Bracco Imaging MRI Contrast Agents Production Capacity, Value and Gross Margin (2018-2023)
  4.3.4 Bracco Imaging Product Portfolio
  4.3.5 Bracco Imaging Recent Developments
4.4 GE Healthcare
  4.4.1 GE Healthcare MRI Contrast Agents Company Information
  4.4.2 GE Healthcare MRI Contrast Agents Business Overview
  4.4.3 GE Healthcare MRI Contrast Agents Production Capacity, Value and Gross Margin (2018-2023)
  4.4.4 GE Healthcare Product Portfolio
  4.4.5 GE Healthcare Recent Developments
4.5 BeiLu Pharma
  4.5.1 BeiLu Pharma MRI Contrast Agents Company Information
  4.5.2 BeiLu Pharma MRI Contrast Agents Business Overview
  4.5.3 BeiLu Pharma MRI Contrast Agents Production Capacity, Value and Gross Margin (2018-2023)
  4.5.4 BeiLu Pharma Product Portfolio
  4.5.5 BeiLu Pharma Recent Developments
4.6 Hengrui Medicine
  4.6.1 Hengrui Medicine MRI Contrast Agents Company Information
  4.6.2 Hengrui Medicine MRI Contrast Agents Business Overview
  4.6.3 Hengrui Medicine MRI Contrast Agents Production Capacity, Value and Gross Margin (2018-2023)
  4.6.4 Hengrui Medicine Product Portfolio
  4.6.5 Hengrui Medicine Recent Developments

5 GLOBAL MRI CONTRAST AGENTS PRODUCTION BY REGION

5.1 Global MRI Contrast Agents Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
5.2 Global MRI Contrast Agents Production by Region: 2018-2029
  5.2.1 Global MRI Contrast Agents Production by Region: 2018-2023
  5.2.2 Global MRI Contrast Agents Production Forecast by Region (2024-2029)
5.3 Global MRI Contrast Agents Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
5.4 Global MRI Contrast Agents Production Value by Region: 2018-2029
  5.4.1 Global MRI Contrast Agents Production Value by Region: 2018-2023
  5.4.2 Global MRI Contrast Agents Production Value Forecast by Region (2024-2029)
5.5 Global MRI Contrast Agents Market Price Analysis by Region (2018-2023)
5.6 Global MRI Contrast Agents Production and Value, YOY Growth
  5.6.1 North America MRI Contrast Agents Production Value Estimates and Forecasts (2018-2029)
  5.6.2 Europe MRI Contrast Agents Production Value Estimates and Forecasts (2018-2029)
  5.6.3 China MRI Contrast Agents Production Value Estimates and Forecasts (2018-2029)
  5.6.4 Japan MRI Contrast Agents Production Value Estimates and Forecasts (2018-2029)

6 GLOBAL MRI CONTRAST AGENTS CONSUMPTION BY REGION

6.1 Global MRI Contrast Agents Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
6.2 Global MRI Contrast Agents Consumption by Region (2018-2029)
  6.2.1 Global MRI Contrast Agents Consumption by Region: 2018-2029
  6.2.2 Global MRI Contrast Agents Forecasted Consumption by Region (2024-2029)
6.3 North America
  6.3.1 North America MRI Contrast Agents Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
  6.3.2 North America MRI Contrast Agents Consumption by Country (2018-2029)
  6.3.3 United States
  6.3.4 Canada
6.4 Europe
  6.4.1 Europe MRI Contrast Agents Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
  6.4.2 Europe MRI Contrast Agents Consumption by Country (2018-2029)
  6.4.3 Germany
  6.4.4 France
  6.4.5 U.K.
  6.4.6 Italy
  6.4.7 Russia
6.5 Asia Pacific
  6.5.1 Asia Pacific MRI Contrast Agents Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
  6.5.2 Asia Pacific MRI Contrast Agents Consumption by Country (2018-2029)
  6.5.3 China
  6.5.4 Japan
  6.5.5 South Korea
  6.5.6 China Taiwan
  6.5.7 Southeast Asia
  6.5.8 India
  6.5.9 Australia
6.6 Latin America, Middle East & Africa
  6.6.1 Latin America, Middle East & Africa MRI Contrast Agents Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
  6.6.2 Latin America, Middle East & Africa MRI Contrast Agents Consumption by Country (2018-2029)
  6.6.3 Mexico
  6.6.4 Brazil
  6.6.5 Turkey
  6.6.5 GCC Countries

7 SEGMENT BY TYPE

7.1 Global MRI Contrast Agents Production by Type (2018-2029)
  7.1.1 Global MRI Contrast Agents Production by Type (2018-2029) & (Liter)
  7.1.2 Global MRI Contrast Agents Production Market Share by Type (2018-2029)
7.2 Global MRI Contrast Agents Production Value by Type (2018-2029)
  7.2.1 Global MRI Contrast Agents Production Value by Type (2018-2029) & (US$ Million)
  7.2.2 Global MRI Contrast Agents Production Value Market Share by Type (2018-2029)
7.3 Global MRI Contrast Agents Price by Type (2018-2029)

8 SEGMENT BY APPLICATION

8.1 Global MRI Contrast Agents Production by Application (2018-2029)
  8.1.1 Global MRI Contrast Agents Production by Application (2018-2029) & (Liter)
  8.1.2 Global MRI Contrast Agents Production by Application (2018-2029) & (Liter)
8.2 Global MRI Contrast Agents Production Value by Application (2018-2029)
  8.2.1 Global MRI Contrast Agents Production Value by Application (2018-2029) & (US$ Million)
  8.2.2 Global MRI Contrast Agents Production Value Market Share by Application (2018-2029)
8.3 Global MRI Contrast Agents Price by Application (2018-2029)

9 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET

9.1 MRI Contrast Agents Value Chain Analysis
  9.1.1 MRI Contrast Agents Key Raw Materials
  9.1.2 Raw Materials Key Suppliers
  9.1.3 MRI Contrast Agents Production Mode & Process
9.2 MRI Contrast Agents Sales Channels Analysis
  9.2.1 Direct Comparison with Distribution Share
  9.2.2 MRI Contrast Agents Distributors
  9.2.3 MRI Contrast Agents Customers

10 GLOBAL MRI CONTRAST AGENTS ANALYZING MARKET DYNAMICS

10.1 MRI Contrast Agents Industry Trends
10.2 MRI Contrast Agents Industry Drivers
10.3 MRI Contrast Agents Industry Opportunities and Challenges
10.4 MRI Contrast Agents Industry Restraints

11 REPORT CONCLUSION


12 DISCLAIMER


LIST OF TABLES

Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global MRI Contrast Agents Production by Manufacturers (Liter) & (2018-2023)
Table 6. Global MRI Contrast Agents Production Market Share by Manufacturers
Table 7. Global MRI Contrast Agents Production Value by Manufacturers (US$ Million) & (2018-2023)
Table 8. Global MRI Contrast Agents Production Value Market Share by Manufacturers (2018-2023)
Table 9. Global MRI Contrast Agents Average Price (US$/mL) of Key Manufacturers (2018-2023)
Table 10. Global MRI Contrast Agents Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 11. Global MRI Contrast Agents Manufacturers, Product Type & Application
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global MRI Contrast Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 15. Bayer MRI Contrast Agents Company Information
Table 16. Bayer Business Overview
Table 17. Bayer MRI Contrast Agents Production Capacity (Liter), Value (US$ Million), Price (US$/mL) and Gross Margin (2018-2023)
Table 18. Bayer Product Portfolio
Table 19. Bayer Recent Developments
Table 20. Guerbet Group MRI Contrast Agents Company Information
Table 21. Guerbet Group Business Overview
Table 22. Guerbet Group MRI Contrast Agents Production Capacity (Liter), Value (US$ Million), Price (US$/mL) and Gross Margin (2018-2023)
Table 23. Guerbet Group Product Portfolio
Table 24. Guerbet Group Recent Developments
Table 25. Bracco Imaging MRI Contrast Agents Company Information
Table 26. Bracco Imaging Business Overview
Table 27. Bracco Imaging MRI Contrast Agents Production Capacity (Liter), Value (US$ Million), Price (US$/mL) and Gross Margin (2018-2023)
Table 28. Bracco Imaging Product Portfolio
Table 29. Bracco Imaging Recent Developments
Table 30. GE Healthcare MRI Contrast Agents Company Information
Table 31. GE Healthcare Business Overview
Table 32. GE Healthcare MRI Contrast Agents Production Capacity (Liter), Value (US$ Million), Price (US$/mL) and Gross Margin (2018-2023)
Table 33. GE Healthcare Product Portfolio
Table 34. GE Healthcare Recent Developments
Table 35. BeiLu Pharma MRI Contrast Agents Company Information
Table 36. BeiLu Pharma Business Overview
Table 37. BeiLu Pharma MRI Contrast Agents Production Capacity (Liter), Value (US$ Million), Price (US$/mL) and Gross Margin (2018-2023)
Table 38. BeiLu Pharma Product Portfolio
Table 39. BeiLu Pharma Recent Developments
Table 40. Hengrui Medicine MRI Contrast Agents Company Information
Table 41. Hengrui Medicine Business Overview
Table 42. Hengrui Medicine MRI Contrast Agents Production Capacity (Liter), Value (US$ Million), Price (US$/mL) and Gross Margin (2018-2023)
Table 43. Hengrui Medicine Product Portfolio
Table 44. Hengrui Medicine Recent Developments
Table 45. Global MRI Contrast Agents Production Comparison by Region: 2018 VS 2022 VS 2029 (Liter)
Table 46. Global MRI Contrast Agents Production by Region (2018-2023) & (Liter)
Table 47. Global MRI Contrast Agents Production Market Share by Region (2018-2023)
Table 48. Global MRI Contrast Agents Production Forecast by Region (2024-2029) & (Liter)
Table 49. Global MRI Contrast Agents Production Market Share Forecast by Region (2024-2029)
Table 50. Global MRI Contrast Agents Production Value Comparison by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 51. Global MRI Contrast Agents Production Value by Region (2018-2023) & (US$ Million)
Table 52. Global MRI Contrast Agents Production Value Market Share by Region (2018-2023)
Table 53. Global MRI Contrast Agents Production Value Forecast by Region (2024-2029) & (US$ Million)
Table 54. Global MRI Contrast Agents Production Value Market Share Forecast by Region (2024-2029)
Table 55. Global MRI Contrast Agents Market Average Price (US$/mL) by Region (2018-2023)
Table 56. Global MRI Contrast Agents Consumption Comparison by Region: 2018 VS 2022 VS 2029 (Liter)
Table 57. Global MRI Contrast Agents Consumption by Region (2018-2023) & (Liter)
Table 58. Global MRI Contrast Agents Consumption Market Share by Region (2018-2023)
Table 59. Global MRI Contrast Agents Forecasted Consumption by Region (2024-2029) & (Liter)
Table 60. Global MRI Contrast Agents Forecasted Consumption Market Share by Region (2024-2029)
Table 61. North America MRI Contrast Agents Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Liter)
Table 62. North America MRI Contrast Agents Consumption by Country (2018-2023) & (Liter)
Table 63. North America MRI Contrast Agents Consumption by Country (2024-2029) & (Liter)
Table 64. Europe MRI Contrast Agents Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Liter)
Table 65. Europe MRI Contrast Agents Consumption by Country (2018-2023) & (Liter)
Table 66. Europe MRI Contrast Agents Consumption by Country (2024-2029) & (Liter)
Table 67. Asia Pacific MRI Contrast Agents Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Liter)
Table 68. Asia Pacific MRI Contrast Agents Consumption by Country (2018-2023) & (Liter)
Table 69. Asia Pacific MRI Contrast Agents Consumption by Country (2024-2029) & (Liter)
Table 70. Latin America, Middle East & Africa MRI Contrast Agents Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Liter)
Table 71. Latin America, Middle East & Africa MRI Contrast Agents Consumption by Country (2018-2023) & (Liter)
Table 72. Latin America, Middle East & Africa MRI Contrast Agents Consumption by Country (2024-2029) & (Liter)
Table 73. Global MRI Contrast Agents Production by Type (2018-2023) & (Liter)
Table 74. Global MRI Contrast Agents Production by Type (2024-2029) & (Liter)
Table 75. Global MRI Contrast Agents Production Market Share by Type (2018-2023)
Table 76. Global MRI Contrast Agents Production Market Share by Type (2024-2029)
Table 77. Global MRI Contrast Agents Production Value by Type (2018-2023) & (US$ Million)
Table 78. Global MRI Contrast Agents Production Value by Type (2024-2029) & (US$ Million)
Table 79. Global MRI Contrast Agents Production Value Market Share by Type (2018-2023)
Table 80. Global MRI Contrast Agents Production Value Market Share by Type (2024-2029)
Table 81. Global MRI Contrast Agents Price by Type (2018-2023) & (US$/mL)
Table 82. Global MRI Contrast Agents Price by Type (2024-2029) & (US$/mL)
Table 83. Global MRI Contrast Agents Production by Application (2018-2023) & (Liter)
Table 84. Global MRI Contrast Agents Production by Application (2024-2029) & (Liter)
Table 85. Global MRI Contrast Agents Production Market Share by Application (2018-2023)
Table 86. Global MRI Contrast Agents Production Market Share by Application (2024-2029)
Table 87. Global MRI Contrast Agents Production Value by Application (2018-2023) & (US$ Million)
Table 88. Global MRI Contrast Agents Production Value by Application (2024-2029) & (US$ Million)
Table 89. Global MRI Contrast Agents Production Value Market Share by Application (2018-2023)
Table 90. Global MRI Contrast Agents Production Value Market Share by Application (2024-2029)
Table 91. Global MRI Contrast Agents Price by Application (2018-2023) & (US$/mL)
Table 92. Global MRI Contrast Agents Price by Application (2024-2029) & (US$/mL)
Table 93. Key Raw Materials
Table 94. Raw Materials Key Suppliers
Table 95. MRI Contrast Agents Distributors List
Table 96. MRI Contrast Agents Customers List
Table 97. MRI Contrast Agents Industry Trends
Table 98. MRI Contrast Agents Industry Drivers
Table 99. MRI Contrast Agents Industry Restraints
Table 100. Authors List of This Report

LIST OF FIGURES

Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. MRI Contrast AgentsProduct Picture
Figure 5. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Figure 6. Gadobutrol Product Picture
Figure 7. Gadoterate Meglumine Product Picture
Figure 8. Gadobenate Dimeglumine Product Picture
Figure 9. Gadopentetate Dimeglumine Product Picture
Figure 10. Gadoteridol Product Picture
Figure 11. Gadodiamine Product Picture
Figure 12. Others Product Picture
Figure 13. Hospitals Product Picture
Figure 14. Clinics Product Picture
Figure 15. Global MRI Contrast Agents Production Value (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global MRI Contrast Agents Production Value (2018-2029) & (US$ Million)
Figure 17. Global MRI Contrast Agents Production Capacity (2018-2029) & (Liter)
Figure 18. Global MRI Contrast Agents Production (2018-2029) & (Liter)
Figure 19. Global MRI Contrast Agents Average Price (US$/mL) & (2018-2029)
Figure 20. Global MRI Contrast Agents Key Manufacturers, Manufacturing Sites & Headquarters
Figure 21. Global MRI Contrast Agents Manufacturers, Date of Enter into This Industry
Figure 22. Global Top 5 and 10 MRI Contrast Agents Players Market Share by Production Valu in 2022
Figure 23. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Global MRI Contrast Agents Production Comparison by Region: 2018 VS 2022 VS 2029 (Liter)
Figure 25. Global MRI Contrast Agents Production Market Share by Region: 2018 VS 2022 VS 2029
Figure 26. Global MRI Contrast Agents Production Value Comparison by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 27. Global MRI Contrast Agents Production Value Market Share by Region: 2018 VS 2022 VS 2029
Figure 28. North America MRI Contrast Agents Production Value (US$ Million) Growth Rate (2018-2029)
Figure 29. Europe MRI Contrast Agents Production Value (US$ Million) Growth Rate (2018-2029)
Figure 30. China MRI Contrast Agents Production Value (US$ Million) Growth Rate (2018-2029)
Figure 31. Japan MRI Contrast Agents Production Value (US$ Million) Growth Rate (2018-2029)
Figure 32. Global MRI Contrast Agents Consumption Comparison by Region: 2018 VS 2022 VS 2029 (Liter)
Figure 33. Global MRI Contrast Agents Consumption Market Share by Region: 2018 VS 2022 VS 2029
Figure 34. North America MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 35. North America MRI Contrast Agents Consumption Market Share by Country (2018-2029)
Figure 36. United States MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 37. Canada MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 38. Europe MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 39. Europe MRI Contrast Agents Consumption Market Share by Country (2018-2029)
Figure 40. Germany MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 41. France MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 42. U.K. MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 43. Italy MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 44. Netherlands MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 45. Asia Pacific MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 46. Asia Pacific MRI Contrast Agents Consumption Market Share by Country (2018-2029)
Figure 47. China MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 48. Japan MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 49. South Korea MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 50. China Taiwan MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 51. Southeast Asia MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 52. India MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 53. Australia MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 54. Latin America, Middle East & Africa MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 55. Latin America, Middle East & Africa MRI Contrast Agents Consumption Market Share by Country (2018-2029)
Figure 56. Mexico MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 57. Brazil MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 58. Turkey MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 59. GCC Countries MRI Contrast Agents Consumption and Growth Rate (2018-2029) & (Liter)
Figure 60. Global MRI Contrast Agents Production Market Share by Type (2018-2029)
Figure 61. Global MRI Contrast Agents Production Value Market Share by Type (2018-2029)
Figure 62. Global MRI Contrast Agents Price (US$/mL) by Type (2018-2029)
Figure 63. Global MRI Contrast Agents Production Market Share by Application (2018-2029)
Figure 64. Global MRI Contrast Agents Production Value Market Share by Application (2018-2029)
Figure 65. Global MRI Contrast Agents Price (US$/mL) by Application (2018-2029)
Figure 66. MRI Contrast Agents Value Chain
Figure 67. MRI Contrast Agents Production Mode & Process
Figure 68. Direct Comparison with Distribution Share
Figure 69. Distributors Profiles
Figure 70. MRI Contrast Agents Industry Opportunities and Challenges


More Publications